Related Experiment Video
Updated: May 8, 2026

02:22
Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
Published on: April 12, 2024
Hirayama disease: Is surgery an option?
M Agundez1, I Rouco1, J Barcena1
1Servicio de Neurología, Hospital Universitario de Cruces, Departamento de Neurociencias, Universidad del País Vasco.
Neurologia (Barcelona, Spain)
|August 24, 2013
Summary
Hirayama disease, a rare cervical myelopathy, often stabilizes naturally. Surgery is typically reserved for severe, rapidly progressing cases of this condition.
Area of Science:
- Neurology
- Spinal Cord Diseases
Background:
- Hirayama disease (HD) is a rare cervical myelopathy primarily affecting young males.
- Characterized by distal upper limb atrophy, it requires differentiation from motor neuron diseases due to its distinct natural history and tendency to stabilize within 5 years.
Observation:
- Four cases of Hirayama disease diagnosed via clinical and dynamic MRI criteria were analyzed.
- Two cases showed spontaneous stabilization over many years with resolution of typical MRI changes.
- One case stabilized with shorter observation, while a fourth rapidly progressing case underwent surgery and remains stable.
Findings:
- Most Hirayama disease patients experience natural stabilization.
- Dynamic flexion MRI is crucial for diagnosing HD, revealing segmental spinal muscular atrophy, posterior dural detachment, and epidural venous congestion.
Implications:
- Hirayama disease management should prioritize conservative treatment.
- Surgical intervention should be considered on a case-by-case basis, reserved for severe, rapidly progressing myelopathy.
Related Concept Videos
Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...